Assignee
CELLPHIRE INC
US·14 granted patents·36 pending applications·87 citations·filing 2005–2025
Top patents by PatentIndex Score
50 records- 0196US11529587B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2020·Granted Dec 20, 2022·15 cites·29 claims
- 0295US11752468B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2022·Granted Sep 12, 2023·7 cites·25 claims
- 0395US11701388B2Thrombosomes as an antiplatelet agent reversal agentCELLPHIRE INC·Filed 2020·Granted Jul 18, 2023·10 cites·22 claims
- 0495US7811558B2Use of stabilized platelets as hemostatic agentCELLPHIRE INC·Filed 2005·Granted Oct 12, 2010·42 cites·13 claims
- 0594US11813572B2Materials and methods for producing blood productsCELLPHIRE INC·Filed 2023·Granted Nov 14, 2023·5 cites·30 claims
- 0693US12208122B2Methods of treating bleeding in a subject treated with an antiplatelet agentCELLPHIRE INC·Filed 2024·Granted Jan 28, 2025·2 cites·30 claims
- 0792US11767511B2Platelets as delivery agentsCELLPHIRE INC·Filed 2019·Granted Sep 26, 2023·6 cites·22 claims
- 0883US12295972B2Methods using freeze-dried platelet derivative compositions for restoring hemostasis in a subjectCELLPHIRE INC·Filed 2024·Granted May 13, 2025·0 cites·30 claims
- 0979US12419914B2Thrombosomes as an antiplatelet agent reversal agentCELLPHIRE INC·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 1079US2025302880A1Platelet derivative compositions in the form of a powderCELLPHIRE INC·Filed 2025·Application pending·0 cites
- 1178US12378523B2Platelets as delivery agentsCELLPHIRE INC·Filed 2023·Granted Aug 5, 2025·0 cites·20 claims
- 1276US12370219B2Platelet derivative compositions, and pluralities of containers containing sameCELLPHIRE INC·Filed 2025·Granted Jul 29, 2025·0 cites·21 claims
- 1376US2023356150A1Materials and methods for producing blood productsCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 1474US2024254443A1Platelet diagnostic imaging agentsCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 1573US12290532B2Treatment of von Willebrand diseaseCELLPHIRE INC·Filed 2024·Granted May 6, 2025·0 cites·20 claims
- 1673US2022273724A1Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 1770US2023346839A1Blood plasma-containing compositionsCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 1868US2025000908A1Methods for preparing and administering cryopreserved platelets and platelet derivatives loaded with anti-cancer drugsCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 1967US2025064856A1Methods for administering platelet derivative compositions to subjects afflicted with hermansky pudlak syndrome or bernard soulier syndromeCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 2065US2025064988A1Mri-agent loaded platelet compositions and methods of preparing and using the sameCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 2165US2025073271A1Methods of administering platelet derivative compositions to reduce bleeding in subjects refractory to platelet transfusionCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 2265US2023248772A1Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healingCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 2364US2024066065A1Platelet derivatives for treating coagulopathyCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 2463US11903971B2Treatment of von Willebrand diseaseCELLPHIRE INC·Filed 2021·Granted Feb 20, 2024·0 cites·20 claims
- 2562US2020078407A1Blood plasma-containing compositionsCELLPHIRE INC·Filed 2019·Application pending·0 cites
- 2662US2024307453A1Methods for controlling bleeding in a subject afflicted with hermansky pudlak syndrome using platelet derivative compositionsCELLPHIRE INC·Filed 2024·Application pending·0 cites
- 2761US2021353680A1Blood plasma-containing compositionsCELLPHIRE INC·Filed 2021·Application pending·0 cites
- 2861US2021368782A1Nucleated cell preservation by lyophilizationCELLPHIRE INC·Filed 2021·Application pending·0 cites
- 2961US2023248771A1Platelets loaded with anti-cancer agentsCELLPHIRE INC·Filed 2023·Application pending·0 cites
- 3060US2023112136A1Canine blood platelet preparationsCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 3160US2023149467A1Platelet derivative compositions, and methods of making and using such compositionsCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 3260US2021189341A1Platelet diagnostic imaging agentsCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 3359US2023149468A1Platelet derived extracellular vesiclesCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 3457US11965178B2Platelets loaded with anti-cancer agentsCELLPHIRE INC·Filed 2019·Granted Apr 23, 2024·0 cites·15 claims
- 3557US2022279777A1Freeze-dried platelet derivative compositions for treating anticoagulant-induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 3656US2021180016A1PLATELETS LOADED WITH mRNACELLPHIRE INC·Filed 2020·Application pending·0 cites
- 3756US2022211029A1Freeze-dried peripheral blood mononuclear cell compositions and methodsCELLPHIRE INC·Filed 2021·Application pending·0 cites
- 3856US2022168353A1Freeze-dried platelet derivative compositions for treating antiplatelet induced coagulopathyCELLPHIRE INC·Filed 2022·Application pending·0 cites
- 3953US2021046120A1Thrombosomes as an anticoagulant reversal agentCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 4052US2020046771A1Cryopreserved platelet compositions and methods for makingCELLPHIRE INC·Filed 2019·Application pending·0 cites
- 4150US2021100846A1Use of platelets in treating infectionsCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 4250US2021069240A1Materials and methods for blood plasma preparationsCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 4348US2020291356A1Canine blood platelet preparationsCELLPHIRE INC·Filed 2020·Application pending·0 cites
- 4448US2019008143A1Nucleated cell preservation by lyophilizationCELLPHIRE INC·Filed 2017·Application pending·0 cites
- 4547US2019076478A1Canine blood platelet preparationsCELLPHIRE INC·Filed 2018·Application pending·0 cites
- 4647US2025177450A1Methods for administering freeze-dried platelet derivative compositions to subjects treated with a factor xi inhibitorCELLPHIRE INC·Filed 2025·Application pending·0 cites
- 4744US2020093853A1Compositions and methods for treatment of loss of fluids leading to hypotension and/or hypovolemiaCELLPHIRE INC·Filed 2016·Application pending·0 cites
- 4843US2020281980A1Products and methods using a platelet-derived hemostatic agent for controlling bleeding and improving healingCELLPHIRE INC·Filed 2016·Application pending·0 cites
- 4942US2017333593A1Products and devices for controlling and stopping bleeding and methods of usingCELLPHIRE INC·Filed 2015·Application pending·0 cites
- 5041US2018169139A1Composition and methods for treatment of loss of fluids leading to hypotension and/or hypovolemiaCELLPHIRE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLPHIRE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →